Show simple item record

dc.contributor.authorUS Preventive Services Task Force
dc.contributor.authorOwens, Douglas K.
dc.contributor.authorPbert, Lori
dc.date2022-08-11T08:10:19.000
dc.date.accessioned2022-08-23T17:04:06Z
dc.date.available2022-08-23T17:04:06Z
dc.date.issued2020-03-02
dc.date.submitted2020-04-08
dc.identifier.citation<p>US Preventive Services Task Force, Owens DK, Davidson KW, Krist AH, Barry MJ, Cabana M, Caughey AB, Donahue K, Doubeni CA, Epling JW Jr, Kubik M, Ogedegbe G, Pbert L, Silverstein M, Simon MA, Tseng CW, Wong JB. Screening for Hepatitis C Virus Infection in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2020 Mar 2;323(10):970-975. doi: 10.1001/jama.2020.1123. PMID: 32119076. <a href="https://doi.org/10.1001/jama.2020.1123">Link to article on publisher's site</a></p>
dc.identifier.issn0098-7484 (Linking)
dc.identifier.doi10.1001/jama.2020.1123
dc.identifier.pmid32119076
dc.identifier.urihttp://hdl.handle.net/20.500.14038/44568
dc.description<p>Full author list omitted for brevity. For the full list of authors, see article.</p>
dc.description.abstractImportance: Hepatitis C virus (HCV) is the most common chronic blood-borne pathogen in the US and a leading cause of complications from chronic liver disease. HCV is associated with more deaths than the top 60 other reportable infectious diseases combined, including HIV. Cases of acute HCV infection have increased approximately 3.8-fold over the last decade because of increasing injection drug use and improved surveillance. Objective: To update its 2013 recommendation, the USPSTF commissioned a review of the evidence on screening for HCV infection in adolescents and adults. Population: This recommendation applies to all asymptomatic adults aged 18 to 79 years without known liver disease. Evidence Assessment: The USPSTF concludes with moderate certainty that screening for HCV infection in adults aged 18 to 79 years has substantial net benefit. Recommendation: The USPSTF recommends screening for HCV infection in adults aged 18 to 79 years. (B recommendation).
dc.language.isoen_US
dc.relation<p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=32119076&dopt=Abstract">Link to Article in PubMed</a></p>
dc.rights© 2020 American Medical Association. Publisher PDF posted after 6 months as allowed by publisher's policy at https://jamanetwork.com/journals/jama/pages/instructions-for-authors#SecDepositingResearchArticlesinApprovedPublicRepositories.
dc.subjectScreening
dc.subjectHepatitis C
dc.subjectHCV
dc.subjectrecommendations
dc.subjectBehavioral Medicine
dc.subjectCommunity Health and Preventive Medicine
dc.subjectHealth Services Administration
dc.subjectHealth Services Research
dc.subjectPreventive Medicine
dc.subjectVirus Diseases
dc.titleScreening for Hepatitis C Virus Infection in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement
dc.typeArticle
dc.source.journaltitleJAMA
dc.source.volume323
dc.source.issue10
dc.identifier.legacyfulltexthttps://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=1161&amp;context=prc_pubs&amp;unstamped=1
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/prc_pubs/161
dc.legacy.embargo2020-08-02T00:00:00-07:00
dc.identifier.contextkey17315089
refterms.dateFOA2022-08-23T17:04:06Z
html.description.abstract<p>Importance: Hepatitis C virus (HCV) is the most common chronic blood-borne pathogen in the US and a leading cause of complications from chronic liver disease. HCV is associated with more deaths than the top 60 other reportable infectious diseases combined, including HIV. Cases of acute HCV infection have increased approximately 3.8-fold over the last decade because of increasing injection drug use and improved surveillance.</p> <p>Objective: To update its 2013 recommendation, the USPSTF commissioned a review of the evidence on screening for HCV infection in adolescents and adults.</p> <p>Population: This recommendation applies to all asymptomatic adults aged 18 to 79 years without known liver disease.</p> <p>Evidence Assessment: The USPSTF concludes with moderate certainty that screening for HCV infection in adults aged 18 to 79 years has substantial net benefit.</p> <p>Recommendation: The USPSTF recommends screening for HCV infection in adults aged 18 to 79 years. (B recommendation).</p>
dc.identifier.submissionpathprc_pubs/161
dc.contributor.departmentUMass Worcester Prevention Research Center
dc.contributor.departmentDepartment of Population and Quantitative Health Sciences, Division of Preventive and Behavioral Medicine
dc.source.pages970-975


Files in this item

Thumbnail
Name:
jama_owens_2020_us_200003.pdf
Size:
465.3Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record